Xilio Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Xilio Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Xilio Therapeutics Inc
Rating: 1.43008325
Author: Trendlyne DVM scores

about

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...

0.68 0.01 (1.49%)

60.00% Fall from 52W High

209.3K

XNAS Volume

XNAS 05 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

14.8 / 100

Technically Neutral

42.4 / 100

1Yr Price target upside is 194%

1 analysts

Xilio Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Xilio Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...

60.00% Fall from 52W High

SWOT Analysis

Xilio Therapeutics Inc Live Price Chart